Hepatorenal Syndrome (HRS) is a serious medical condition characterized by the dysfunction of both the liver and kidneys. It occurs in individuals with advanced liver disease, such as cirrhosis, and is typically a result of impaired blood flow to the kidneys.
The **primary feature** of HRS is the development of kidney failure, which is often sudden and severe. This can lead to a significant decline in kidney function, causing a buildup of waste products and fluid retention in the body. As a result, affected individuals may experience symptoms like decreased urine output, swelling in the legs and abdomen, fatigue, and confusion.
HRS is considered a **life-threatening condition** and requires immediate medical attention. It is important to differentiate HRS from other causes of kidney failure in order to provide appropriate treatment. Diagnosis is typically based on clinical evaluation, laboratory tests, and exclusion of other potential causes.
Treatment for HRS aims to improve kidney function and manage the underlying liver disease. This may involve interventions such as medication to increase blood flow to the kidneys, fluid and electrolyte management, and in some cases, liver transplantation.
Overall, Hepatorenal Syndrome is a critical condition that necessitates prompt medical intervention to prevent further complications and improve patient outcomes.